Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.78M Buy
7,889
+411
+5% +$147K 0.71% 40
2025
Q4
$2.45M Buy
7,478
+55
+0.7% +$17.4K 0.6% 42
2025
Q3
$2.09M Buy
7,423
+153
+2% +$44.4K 0.52% 48
2025
Q2
$2.03M Sell
7,270
-262
-3% -$74.2K 0.54% 46
2025
Q1
$2.35M Sell
7,532
-13,712
-65% -$4.05M 0.65% 43
2024
Q4
$5.54M Sell
21,244
-1,069
-5% -$317K 1.47% 18
2024
Q3
$7.19M Sell
22,313
-2,816
-11% -$921K 1.86% 13
2024
Q2
$7.85M Buy
25,129
+987
+4% +$290K 2.11% 10
2024
Q1
$6.86M Buy
24,142
+8,893
+58% +$2.6M 1.95% 13
2023
Q4
$4.39M Buy
15,249
+1,871
+14% +$510K 1.37% 24
2023
Q3
$3.6M Sell
13,378
-9,475
-41% -$2.36M 1.29% 23
2023
Q2
$5.07M Buy
22,853
+614
+3% +$142K 1.8% 14
2023
Q1
$5.38M Buy
22,239
+818
+4% +$201K 2.11% 9
2022
Q4
$5.63M Buy
21,421
+721
+3% +$193K 2.59% 8
2022
Q3
$4.67M Buy
20,700
+1,266
+7% +$307K 2.29% 9
2022
Q2
$4.73M Buy
19,434
+339
+2% +$83.1K 2.29% 13
2022
Q1
$4.62M Sell
19,095
-1,416
-7% -$325K 1.92% 13
2021
Q4
$4.61M Sell
20,511
-64
-0.3% -$13.5K 1.69% 16
2021
Q3
$4.38M Buy
20,575
+1,116
+6% +$257K 1.78% 12
2021
Q2
$4.74M Buy
19,459
+1,015
+6% +$250K 2.05% 10
2021
Q1
$4.59M Buy
18,444
+1,151
+7% +$275K 2.26% 11
2020
Q4
$3.98M Buy
17,293
+416
+2% +$95.9K 2.2% 10
2020
Q3
$4.29M Buy
16,877
+230
+1% +$57K 2.66% 7
2020
Q2
$3.93M Sell
16,647
-1,408
-8% -$321K 2.71% 7
2020
Q1
$3.66M Sell
18,055
-296
-2% -$64.7K 3.05% 5
2019
Q4
$4.42M Sell
18,351
-544
-3% -$120K 3.2% 6
2019
Q3
$3.66M Buy
18,895
+247
+1% +$47.4K 3.12% 7
2019
Q2
$3.44M Buy
18,648
+978
+6% +$175K 2.47% 7
2019
Q1
$3.36M Sell
17,670
-179
-1% -$34.2K 2.6% 8
2018
Q4
$3.48M Sell
17,849
-266
-1% -$51.9K 3.16% 8
2018
Q3
$3.75M Buy
18,115
+125
+0.7% +$24.6K 2.83% 8
2018
Q2
$3.32M Buy
17,990
+142
+0.8% +$25.1K 2.71% 8
2018
Q1
$3.04M Buy
17,848
+3,236
+22% +$594K 2.57% 9
2017
Q4
$2.54M Buy
+14,612
New +$2.59M 2.38% 11

Other funds holding AMGN

Arjuna Capital's AMGN Position: Q1 2026 in Review

Arjuna Capital increased its Amgen (AMGN) stake by 5.5% in Q1 2026, buying an estimated $147K and bringing the position to 7,889 shares worth $2.78M. The position accounts for 0.71% of the portfolio, ranked #40.

Arjuna Capital first reported a position in AMGN in Q4 2017 and has held it in 34 quarters since. The position peaked at $7.85M in Q2 2024. 3,130 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Arjuna Capital held 7,889 shares of Amgen worth $2.78M as of Q1 2026.
  • Arjuna Capital bought 411 Amgen shares in Q1 2026, an estimated $147K.
  • Amgen made up 0.71% of Arjuna Capital's portfolio in Q1 2026, its #40 holding.
  • Arjuna Capital first reported a position in Amgen in Q4 2017 and has held it in 34 quarters since.
  • Arjuna Capital's Amgen position peaked at $7.85M in Q2 2024.
  • 3,130 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Arjuna Capital's 13F filing for Q1 2026, filed 6 May 2026.